rs755177846

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PS3PM2PP3_ModeratePP5

The NM_005993.5(TBCD):​c.3365C>T​(p.Pro1122Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,611,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV002511733: Experimental evidence demonstrated an extremely reduced TBCD protein level and partial loss of protein binding capacity with other components (Flex_2016, Miyake_2016)." and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. P1122P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

TBCD
NM_005993.5 missense

Scores

3
10
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:1

Conservation

PhyloP100: 6.07

Publications

6 publications found
Variant links:
Genes affected
TBCD (HGNC:11581): (tubulin folding cofactor D) Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
TBCD Gene-Disease associations (from GenCC):
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005993.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV002511733: Experimental evidence demonstrated an extremely reduced TBCD protein level and partial loss of protein binding capacity with other components (Flex_2016, Miyake_2016).; SCV002197104: Experimental studies have shown that this missense change affects TBCD function (PMID: 27666370).
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.844
PP5
Variant 17-82938132-C-T is Pathogenic according to our data. Variant chr17-82938132-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 268171.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005993.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBCD
NM_005993.5
MANE Select
c.3365C>Tp.Pro1122Leu
missense
Exon 36 of 39NP_005984.3
TBCD
NM_001411101.1
c.3314C>Tp.Pro1105Leu
missense
Exon 35 of 38NP_001398030.1A0A804HLI2
TBCD
NM_001411102.1
c.3284C>Tp.Pro1095Leu
missense
Exon 35 of 38NP_001398031.1A0A804HJ32

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBCD
ENST00000355528.9
TSL:1 MANE Select
c.3365C>Tp.Pro1122Leu
missense
Exon 36 of 39ENSP00000347719.4Q9BTW9-1
TBCD
ENST00000576677.6
TSL:1
n.3515C>T
non_coding_transcript_exon
Exon 13 of 16
TBCD
ENST00000684760.1
c.3632C>Tp.Pro1211Leu
missense
Exon 37 of 40ENSP00000507696.1A0A804HJY5

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152234
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000690
AC:
17
AN:
246440
AF XY:
0.000104
show subpopulations
Gnomad AFR exome
AF:
0.0000661
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000301
Gnomad EAS exome
AF:
0.000615
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000897
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000158
AC:
23
AN:
1459524
Hom.:
0
Cov.:
36
AF XY:
0.0000179
AC XY:
13
AN XY:
726004
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33418
American (AMR)
AF:
0.00
AC:
0
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.000345
AC:
9
AN:
26104
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39668
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86060
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52966
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4682
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1111744
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152234
Hom.:
0
Cov.:
34
AF XY:
0.0000403
AC XY:
3
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.0000965
AC:
4
AN:
41466
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.000192
AC:
1
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000416

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
1
-
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome (4)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.097
T
BayesDel_noAF
Uncertain
-0.010
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.37
T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.26
D
MetaRNN
Pathogenic
0.84
D
MetaSVM
Benign
-0.37
T
MutationAssessor
Pathogenic
2.9
M
PhyloP100
6.1
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-6.8
D
REVEL
Uncertain
0.36
Sift
Benign
0.12
T
Sift4G
Benign
0.069
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.42
gMVP
0.67
Mutation Taster
=4/96
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs755177846;
hg19: chr17-80896008;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.